{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T20:10:32Z","timestamp":1792440632773,"version":"4.5.0"},"reference-count":32,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCDD"],"abstract":"<jats:p>Transthyretin (TTR) amyloidosis is a systemic, progressive, and fatal disease. TTR is integral in vitamin A (retinol) transport via its binding to retinol binding protein 4 (RBP4). Current and emerging therapies for TTR amyloid cardiomyopathy (ATTR-CM), including RNAi therapies and potentially CRISPR-based therapies, reduce hepatic transthyretin production and hence decrease serum RBP4, which decreases circulating vitamin A levels. However, despite these reductions in circulating vitamin A, hepatic reserves and alternative delivery mechanisms may prevent clinical manifestations of vitamin A deficiency. Vitamin A functions as a key regulator of immunity, antioxidant function, cell growth and differentiation and vision. This paper aims to serve as a comprehensive review of vitamin A and its metabolites, their transport, and their function in human health and disease. Additionally, we seek to synthesize the relevant outcomes and safety data of TTR silencing therapies and how they relate to circulating vitamin A levels and vitamin A-related clinical outcomes in a manner that is relevant to the cardiac amyloidosis specialist.<\/jats:p>","DOI":"10.3390\/jcdd13050205","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T12:33:37Z","timestamp":1778589217000},"page":"205","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Transthyretin and Vitamin A Metabolism: A Review for the Cardiac Amyloidosis Specialist"],"prefix":"10.3390","volume":"13","author":[{"given":"Donclair","family":"Brown","sequence":"first","affiliation":[{"name":"Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY 10467, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishakha","family":"Modak","sequence":"additional","affiliation":[{"name":"Jacobi Medical Center, Albert Einstein College of Medicine, NYC Health and Hospitals, Bronx, NY 10461, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aladin","family":"Altic","sequence":"additional","affiliation":[{"name":"Jacobi Medical Center\/North Central Bronx, Albert Einstein College of Medicine, NYC Health and Hospitals, Bronx, NY 10467, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Al Zuwayny","sequence":"additional","affiliation":[{"name":"Richmond University Medical Center, Staten Island, NY 10310, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1192-392X","authenticated-orcid":false,"given":"James","family":"Tauras","sequence":"additional","affiliation":[{"name":"Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY 10467, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"key":"ref_1","unstructured":"Ross, A.C., and Vitamin, A. (2014). Modern Nutrition in Health and Disease, Lippincott Williams & Wilkins. [11th ed.]."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1080\/09546634.2017.1309349","article-title":"Retinoids: A journey from the molecular structures and mechanisms of action to clinical uses in dermatology and adverse effects","volume":"28","author":"Khalil","year":"2017","journal-title":"J. Dermatol. Treat."},{"key":"ref_3","first-page":"158571","article-title":"The molecular aspects of absorption and metabolism of carotenoids and retinoids in vertebrates","volume":"1865","author":"Golczak","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"645","DOI":"10.22438\/jeb\/45\/6\/MRN-5339","article-title":"A comprehensive review on the role of vitamin A on human health and nutrition","volume":"45","author":"Beer","year":"2024","journal-title":"J. Environ. Biol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e27829","DOI":"10.1097\/MD.0000000000027829","article-title":"Severe types of fetopathy are associated with changes in the serological proteome of diabetic mothers","volume":"100","author":"Kopylov","year":"2021","journal-title":"Medicine"},{"key":"ref_6","unstructured":"Office of Dietary Supplements (2025, October 30). Vitamin A\u2014Health Professional Fact Sheet, Available online: https:\/\/ods.od.nih.gov\/factsheets\/VitaminA-HealthProfessional."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ijvsm.2018.09.003","article-title":"Retinoic acid improves maturation rate and upregulates the expression of antioxidant-related genes in in vitro matured buffalo (Bubalus bubalis) oocytes","volume":"6","author":"Gad","year":"2018","journal-title":"Int. J. Vet. Sci. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1177\/0884533612446706","article-title":"A.S.P.E.N. position paper: Recommendations for changes in commercially available parenteral multivitamin and multi-trace element products","volume":"27","author":"Vanek","year":"2012","journal-title":"Nutr. Clin. Pract."},{"key":"ref_9","unstructured":"(2025, October 30). Drugs and Lactation Database (LactMed\u00ae) [Internet], Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK513060\/."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Carazo, A., Mac\u00e1kov\u00e1, K., Matou\u0161ov\u00e1, K., Kr\u010dmov\u00e1, L.K., Protti, M., and Mlad\u011bnka, P. (2021). Vitamin A Update: Forms, Sources, Kinetics, Detection, Function, Deficiency, Therapeutic Use and Toxicity. Nutrients, 13.","DOI":"10.3390\/nu13051703"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1193S","DOI":"10.3945\/ajcn.112.034850","article-title":"The challenge to reach nutritional adequacy for vitamin A: \u03b2-carotene bioavailability and conversion\u2014evidence in humans","volume":"96","author":"Haskell","year":"2012","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1468S","DOI":"10.3945\/ajcn.2010.28674G","article-title":"Bioconversion of dietary provitamin A carotenoids to vitamin A in humans","volume":"91","author":"Tang","year":"2010","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1017\/S0007114514000166","article-title":"A review of vitamin A equivalency of \u03b2-carotene in various food matrices for human consumption","volume":"111","author":"Naber","year":"2014","journal-title":"Br. J. Nutr."},{"key":"ref_14","first-page":"CD013742","article-title":"Selected laboratory-based biomarkers for assessing vitamin A deficiency in at-risk individuals","volume":"5","author":"Gannon","year":"2025","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Steinhoff, J.S., Lass, A., and Schupp, M. (2022). Retinoid homeostasis and beyond: How retinol-binding protein 4 contributes to health and disease. Nutrients, 14.","DOI":"10.3390\/nu14061236"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"290S","DOI":"10.1093\/jn\/134.1.290S","article-title":"Assessing vitamin A status: Past, present and future","volume":"134","author":"Tanumihardjo","year":"2004","journal-title":"J. Nutr."},{"key":"ref_17","unstructured":"Olson, J.M., Daley, S.F., and Goyal, A. (2025, November 15). Vitamin A Toxicity, StatPearls [Internet], Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK532916\/."},{"key":"ref_18","unstructured":"Marriott, B.P., Birt, D.F., Stallings, V.A., and Yates, A.A. (2020). Vitamin A and provitamin A carotenoids. Present Knowledge in Nutrition, Academic Press. [11th ed.]."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/ajcn\/83.2.191","article-title":"The acute and chronic toxic effects of vitamin A","volume":"83","author":"Penniston","year":"2006","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_20","unstructured":"World Health Organization (2009). Global Prevalence of Vitamin A Deficiency in Populations at Risk 1995\u20132005: WHO Global Database on Vitamin A Deficiency, World Health Organization."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.3748\/wjg.v21.i5.1614","article-title":"High prevalence of vitamin A deficiency in Crohn\u2019s disease patients according to serum retinol levels and the relative dose-response test","volume":"21","author":"Silva","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Xiao, L., Fu, J., Lin, L., and Han, Y. (2022). Temporal trends in incidence of nutritional deficiency among older adults in China: A secondary analysis of the Global Burden of Disease Study 1990\u20132019. Nutrients, 14.","DOI":"10.3390\/nu14235008"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1001\/jama.2023.18688","article-title":"Eplontersen for Hereditary Transthyretin Amyloidosis With Polyneuropathy","volume":"330","author":"Coelho","year":"2023","journal-title":"JAMA"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1080\/13506129.2022.2091985","article-title":"Efficacy and safety of vutrisiran for patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: A randomized clinical trial","volume":"30","author":"Adams","year":"2023","journal-title":"Amyloid"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJMoa2107454","article-title":"CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis","volume":"385","author":"Gillmore","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1056\/NEJMoa2303765","article-title":"Phase 1 Trial of Antibody NI006 for Depletion of Cardiac Transthyretin Amyloid","volume":"389","author":"Donal","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_28","unstructured":"Alnylam Pharmaceuticals, Inc. (2025, October 12). AMVUTTRA (Vutrisiran) [Package Insert]. DailyMed; Revised March 2025, Available online: https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=8db0facb-81b6-4006-9239-27dc6409c5d3."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/jcph.1480","article-title":"Patisiran pharmacokinetics, pharmacodynamics, and exposure-response analyses in the phase 3 APOLLO trial in patients with hereditary transthyretin-mediated amyloidosis","volume":"60","author":"Zhang","year":"2020","journal-title":"J. Clin. Pharmacol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"102066","DOI":"10.1016\/j.jacadv.2025.102066","article-title":"Vutrisiran in transthyretin amyloidosis: A pooled safety analysis of HELIOS-A and HELIOS-B","volume":"4","author":"Witteles","year":"2025","journal-title":"JACC Adv."},{"key":"ref_31","unstructured":"National Library of Medicine (US) (2026, February 22). ONPATTRO\u2014Patisiran Injection, Lipid Complex, Available online: https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=e87ec36f-b4b4-49d4-aea4-d4ffb09b0970."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbapap.2004.09.023","article-title":"Interactions amongst plasma retinol-binding protein, transthyretin and their ligands: Implications in vitamin A homeostasis and transthyretin amyloidosis","volume":"1703","author":"Raghu","year":"2004","journal-title":"Biochim. Biophys. Acta"}],"container-title":["Journal of Cardiovascular Development and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2308-3425\/13\/5\/205\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T13:53:41Z","timestamp":1778594021000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2308-3425\/13\/5\/205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,12]]},"references-count":32,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["jcdd13050205"],"URL":"https:\/\/doi.org\/10.3390\/jcdd13050205","relation":{},"ISSN":["2308-3425"],"issn-type":[{"value":"2308-3425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,12]]}}}